The global molecular oncology market is entering a transformative phase, driven by rapid advancements in genetic research and precision medicine. Valued at US$ 2.3 Bn in 2023, the industry is projected to expand at a robust CAGR of 11.0% between 2024 and 2034, surpassing US$ 7.4 Bn by the end of the forecast period. This strong growth trajectory reflects the increasing importance of...